Serum-mediated Activation of Bone Marrow–derived Mesenchymal Stem Cells in Ischemic Stroke Patients
Gyeong Joon Moon(Asan Medical Center), Oh Young Bang(Samsung Medical Center), Yeon Hee Cho(Samsung Medical Center), Jae Min(Incheon National University), Dong Hee Kim(Samsung Medical Center), Sooyoon Kim(Samsung Medical Center), Ji Hee Sung(Samsung Medical Center), Jeong Pyo Son(Korea Atomic Energy Research Institute)
Cited by 28
Related Papers
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
A Long-Term Follow-Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke
|Stem Cells|2010|764
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
|The Lancet|2020|623
Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data
|The Lancet Neurology|2017|318
Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study
|Translational Stroke Research|2018|177